Stephen Hoge - Nov 2, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
President
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Nov 2, 2021
Transactions value $
-$6,865,600
Form type
4
Date filed
11/4/2021, 04:43 PM
Previous filing
Oct 26, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $9.9K +10K +0.62% $0.99* 1.62M Nov 2, 2021 Direct F1
transaction MRNA Common Stock Sale -$3.39M -10K -0.62% $338.54 1.61M Nov 2, 2021 Direct F1
transaction MRNA Common Stock Options Exercise $9.9K +10K +0.62% $0.99* 1.62M Nov 3, 2021 Direct F1
transaction MRNA Common Stock Sale -$3.5M -10K -0.62% $350.00 1.61M Nov 3, 2021 Direct F1
holding MRNA Common Stock 4.12K Nov 2, 2021 By Valhalla, LLC
holding MRNA Common Stock 152K Nov 2, 2021 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -10K -3.6% $0.00 267K Nov 2, 2021 Common Stock 10K $0.99 Direct F1, F3
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -10K -3.74% $0.00 257K Nov 3, 2021 Common Stock 10K $0.99 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.
F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F3 This option is fully vested and exercisable.